AXITINIB (AXITINIB) — FDA Approval ANDA211650 (APOTEX)
AXITINIB (AXITINIB) — FDA Approval ANDA211650 (APOTEX) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AXITINIB; Active ingredients: AXITINIB; Application number: ANDA211650.
| Brand name | AXITINIB |
|---|---|
| Active ingredients | AXITINIB |
| Application number | ANDA211650 |
| Sponsor | APOTEX |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20251030 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →